Brigatinib is a small-molecule compound used as an active pharmaceutical ingredient. It is designed to inhibit specific receptor tyrosine kinases, including anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR).
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 1197953-54-0
5-Chloro-N2-[4-[4-(dimethylamino)-1-piperidinyl]-2-methoxyphenyl]-N4-[2-(dimethylphosphinyl)phenyl]-2,4-pyrimidinediamine
active pharmaceutical ingredient
6-Methylthioguanine
metabolite of thioguanine drug
3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride
pharmaceutical intermediate
(3S)-1-azabicyclo[2.2.2]octan-3-amine dihydrochloride
active pharmaceutical ingredient
Z944
T-type calcium channel blocker
5-chloro-4-N-(2-dimethylphosphorylphenyl)-2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]pyrimidine-2,4-diamine
AILRADAXUVEEIR-UHFFFAOYSA-N
CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC